Alignment Among Public Formularies in Canada – Part 1: General Overview

List of Selected Drugs

This document provides the complete list of 729 drugs included in the analysis.

blank
Drug* Therapeutic class (ATC level 2)
Code
Therapeutic class (ATC level 2)
Description
Share of drug costs Single source Multi-source High cost
Abatacept L04 Immunosuppressants 0.4%
Acamprosate N07 Other nervous system drugs <0.1%  
Acarbose A10 Drugs used in diabetes <0.1%  
Acebutolol C07 Beta blocking agents <0.1%
Acenocoumarol B01 Antithrombotic agents <0.1%    
Acetazolamide S01 Ophthalmologicals <0.1%    
Acetylcysteine R05 Cough and cold preparations <0.1%    
Acitretin D05 Antipsoriatics <0.1%    
Aclidinium bromide R03 Drugs for obstructive airway diseases <0.1%    
Acyclovir J05 Antivirals for systemic use 0.1%  
Adalimumab L04 Immunosuppressants 3.3%  
Adapalene D10 Anti-acne preparations <0.1%    
Adapalene, combinations D10 Anti-acne preparations <0.1%    
Adefovir dipivoxil J05 Antivirals for systemic use <0.1%  
Alendronic acid M05 Drugs for treatment of bone diseases 0.1%    
Alendronic acid and cholecalciferol M05 Drugs for treatment of bone diseases <0.1%    
Alfa-1 antitrypsin B02 Antihemorrhagics 0.1%
Alfuzosin G04 Urologicals <0.1%  
Alimemazine R06 Antihistamines for systemic use <0.1%    
Aliskiren fumarate C09 Agents acting on the renin-angiotensin system <0.1%    
Alitretinoin D11 Other dermatological preparations <0.1%    
Allopurinol M04 Antigout preparations 0.1%    
Almotriptan N02 Analgesics <0.1%    
Alogliptin benzoate A10 Drugs used in diabetes <0.1%    
Alogliptin benzoate and metformin HCl A10 Drugs used in diabetes <0.1%    
Alprazolam N05 Psycholeptics <0.1%    
Alprostadil C01 Cardiac therapy <0.1%  
Amantadine N04 Anti-Parkinson drugs <0.1%  
Ambrisentan C02 Antihypertensives <0.1%
Amcinonide D07 Corticosteroids, dermatological preparations <0.1%    
Amfetamine N06 Psychoanaleptics <0.1%    
Amikacin J01 Antibacterials for systemic use <0.1%    
Amiloride C03 Diuretics <0.1%    
Amiodarone C01 Cardiac therapy <0.1%    
Amitriptyline N06 Psychoanaleptics 0.1%    
Amlodipine C08 Calcium channel blockers 1.0%  
Amoxicillin J01 Antibacterials for systemic use 0.3%    
Amoxicillin and enzyme inhibitor J01 Antibacterials for systemic use 0.1%    
Amphotericin B J02 Antimycotics for systemic use <0.1%  
Ampicillin J01 Antibacterials for systemic use <0.1%
Anakinra L04 Immunosuppressants <0.1%  
Anethole trithione A16 Other alimentary tract and metabolism products <0.1%    
Antihypertensives for pulmonary arterial hypertension C02 Antihypertensives <0.1%    
Antiinfectives, combinations S03 Ophthalmological and otological preparations <0.1%    
Antispasmodics in combination with other drugs A03 Drugs for functional gastrointestinal disorders <0.1%    
Apixaban B01 Antithrombotic agents 0.6%    
Apraclonidine S01 Ophthalmologicals <0.1%    
Apremilast L04 Immunosuppressants <0.1%    
Aprepitant A04 Antiemetics and antinauseants <0.1%    
Aripiprazole N05 Psycholeptics 0.8%    
Asanepine N05 Psycholeptics <0.1%    
Atenolol C07 Beta blocking agents 0.2%    
Atenolol and other diuretics C07 Beta blocking agents <0.1%    
Atomoxetine N06 Psychoanaleptics <0.1%    
Atorvastatin C10 Lipid modifying agents 1.8%    
Atorvastatin and amlodipine C10 Lipid modifying agents <0.1%    
Atovaquone P01 Antiprotozoals <0.1%  
Atropine A03 Drugs for functional gastrointestinal disorders <0.1%  
Auranofin M01 Antiinflammatory and antirheumatic products <0.1%  
Azathioprine L04 Immunosuppressants <0.1%  
Azelaic acid D10 Anti-acne preparations <0.1%    
Azilsartan medoxomil C09 Agents acting on the renin-angiotensin system <0.1%    
Azithromycin J01 Antibacterials for systemic use 0.1%  
Aztreonam J01 Antibacterials for systemic use <0.1%  
Bacitracin J01 Antibacterials for systemic use <0.1%    
Baclofen M03 Muscle relaxants 0.1%    
Beclometasone D07 Corticosteroids, dermatological preparations <0.1%    
Beclomethasone R01 Nasal preparations <0.1%    
Benazepril C09 Agents acting on the renin-angiotensin system <0.1%    
Benzathine benzylpenicillin J01 Antibacterials for systemic use <0.1%  
Benzatropine N04 Anti-Parkinson drugs <0.1%    
Benzoyl peroxide D10 Anti-acne preparations <0.1%    
Benzylpenicillin J01 Antibacterials for systemic use <0.1%    
Betahistine N07 Other nervous system drugs <0.1%    
Betaine A16 Other alimentary tract and metabolism products <0.1%  
Betamethasone A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents 0.1%    
Betamethasone and antibiotics D07 Corticosteroids, dermatological preparations <0.1%    
Betamethasone and antiinfectives S01 Ophthalmologicals <0.1%    
Betaxolol S01 Ophthalmologicals <0.1%    
Bethanechol N07 Other nervous system drugs <0.1%    
Bezafibrate C10 Lipid modifying agents <0.1%    
Bimatoprost S01 Ophthalmologicals 0.4%    
Bismuth preparations A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%    
Bisoprolol C07 Beta blocking agents 0.1%    
Boceprevir J05 Antivirals for systemic use <0.1%
Bosentan C02 Antihypertensives 0.2%  
Botulinum toxin M03 Muscle relaxants 0.5%  
Brimonidine S01 Ophthalmologicals <0.1%  
Brinzolamide S01 Ophthalmologicals <0.1%    
Brinzolamide, combinations S01 Ophthalmologicals <0.1%    
Bromazepam N05 Psycholeptics <0.1%    
Bromocriptine G02 Other gynecologicals <0.1%    
Budesonide A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents 0.2%    
Bumetanide C03 Diuretics <0.1%  
Bupivacaine N01 Anesthetics <0.1%  
Buprenorphine, combinations N07 Other nervous system drugs 0.2%    
Bupropion N06 Psychoanaleptics 0.3%    
Buserelin L02 Endocrine therapy <0.1%  
Buspirone N05 Psycholeptics <0.1%    
Butorphanol N02 Analgesics <0.1%    
Butylscopolamine A03 Drugs for functional gastrointestinal disorders <0.1%    
Cabergoline G02 Other gynecologicals <0.1%    
Calcipotriol D05 Antipsoriatics <0.1%    
Calcipotriol, combinations D05 Antipsoriatics 0.2%    
Calcitonin (salmon synthetic) H05 Calcium homeostasis <0.1%    
Calcium folinate V03 All other therapeutic products <0.1%    
Canagliflozin A10 Drugs used in diabetes 0.1%  
Candersartan and diuretics C09 Agents acting on the renin-angiotensin system <0.1%    
Candesartan C09 Agents acting on the renin-angiotensin system 0.2%    
Captopril C09 Agents acting on the renin-angiotensin system <0.1%    
Carbamazepine N03 Antiepileptics <0.1%    
Carvedilol C07 Beta blocking agents 0.1%    
Cefaclor J01 Antibacterials for systemic use <0.1%    
Cefadroxil J01 Antibacterials for systemic use <0.1%    
Cefalexin J01 Antibacterials for systemic use 0.2%    
Cefazolin J01 Antibacterials for systemic use <0.1%    
Cefixime J01 Antibacterials for systemic use <0.1%    
Cefotaxime J01 Antibacterials for systemic use <0.1%    
Cefprozil J01 Antibacterials for systemic use <0.1%    
Ceftazidime J01 Antibacterials for systemic use <0.1%    
Ceftriaxone J01 Antibacterials for systemic use <0.1%    
Cefuroxime J01 Antibacterials for systemic use <0.1%    
Celecoxib M01 Antiinflammatory and antirheumatic products 0.2%    
Certolizumab pegol L04 Immunosuppressants 0.1%
Cetirizine R06 Antihistamines for systemic use <0.1%    
Cetrorelix acetate H01 Pituitary and hypothalamic hormones and analogues <0.1%    
Chloral hydrate N05 Psycholeptics <0.1%    
Chloramphenicol J01 Antibacterials for systemic use <0.1%    
Chlordiazepoxide N05 Psycholeptics <0.1%    
Chloroquine P01 Antiprotozoals <0.1%    
Chlorpromazine N05 Psycholeptics <0.1%    
Chlorpropamide A10 Drugs used in diabetes <0.1%    
Chlortalidone C03 Diuretics <0.1%    
Chlorzoxazone, combinations excluding psycholeptics M03 Muscle relaxants <0.1%    
Choline theophyllinate R03 Drugs for obstructive airway diseases <0.1%  
Ciclesonide R03 Drugs for obstructive airway diseases 0.3%  
Ciclopirox D01 Antifungals for dermatological use <0.1%    
Ciclosporin L04 Immunosuppressants 0.2%    
Cilazapril C09 Agents acting on the renin-angiotensin system <0.1%    
Cilazapril and diuretics C09 Agents acting on the renin-angiotensin system <0.1%    
Cimetidine A02 Drugs for acid related disorders <0.1%    
Cinacalcet H05 Calcium homeostasis <0.1%  
Ciprofloxacin J01 Antibacterials for systemic use 0.1%    
Citalopram N06 Psychoanaleptics 0.3%    
Clarithromycin J01 Antibacterials for systemic use 0.1%    
Clidinium and psycholeptics A03 Drugs for functional gastrointestinal disorders <0.1%    
Clindamycin J01 Antibacterials for systemic use <0.1%    
Clindamycin, combinations D10 Anti-acne preparations <0.1%    
Clobazam N05 Psycholeptics <0.1%    
Clobetasol D07 Corticosteroids, dermatological preparations <0.1%    
Clobetasone D07 Corticosteroids, dermatological preparations <0.1%    
Clodronic acid M05 Drugs for treatment of bone diseases <0.1%    
Clomifene G03 Sex hormones and modulators of the genital system <0.1%    
Clomipramine N06 Psychoanaleptics <0.1%    
Clonazepam N03 Antiepileptics 0.1%    
Clonidine C02 Antihypertensives <0.1%    
Clopidogrel B01 Antithrombotic agents 0.5%    
Clorazepate potassium N05 Psycholeptics <0.1%    
Clotrimazole D01 Antifungals for dermatological use <0.1%  
Cloxacillin J01 Antibacterials for systemic use <0.1%    
Clozapine N05 Psycholeptics 0.3%    
Codeine, combinations with psycholeptics N02 Analgesics <0.1%    
Codeine R05 Cough and cold preparations <0.1%    
Codeine, combinations excluding psycholeptics N02 Analgesics 0.3%    
Colchicine M04 Antigout preparations <0.1%    
Colesevelam C10 Lipid modifying agents <0.1%    
Colestipol C10 Lipid modifying agents <0.1%    
Colestyramine C10 Lipid modifying agents 0.1%    
Colistin J01 Antibacterials for systemic use <0.1%    
Collagenase D03 Preparations for treatment of wounds and ulcers <0.1%  
Conjugated estrogens G03 Sex hormones and modulators of the genital system 0.1%    
Cortisone H02 Corticosteroids for systemic use <0.1%    
Cromoglicic acid A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%    
Cyclobenzaprine M03 Muscle relaxants <0.1%    
Cyclopentolate S01 Ophthalmologicals <0.1%    
Cyproterone G03 Sex hormones and modulators of the genital system <0.1%    
Cyproterone and estrogen G03 Sex hormones and modulators of the genital system <0.1%    
Dabigatran etexilate B01 Antithrombotic agents 0.6%    
Dalteparin B01 Antithrombotic agents 0.6%    
Danazol G03 Sex hormones and modulators of the genital system <0.1%    
Dantrolene M03 Muscle relaxants <0.1%    
Dapagliflozin A10 Drugs used in diabetes <0.1%    
Dapsone J04 Antimycobacterials <0.1%    
Daptomycin J01 Antibacterials for systemic use <0.1%    
Darifenacin G04 Urologicals <0.1%    
Dasabuvir, ombitasvir, paritaprevir and ritonavir J05 Antivirals for systemic use 0.1%  
Deferasirox V03 All other therapeutic products 0.2%  
Deferoxamine V03 All other therapeutic products <0.1%  
Denosumab M05 Drugs for treatment of bone diseases 0.6%    
Desipramine N06 Psychoanaleptics <0.1%    
Desmopressin H01 Pituitary and hypothalamic hormones and analogues <0.1%    
Desogestrel and estrogen G03 Sex hormones and modulators of the genital system <0.1%    
Desonide D07 Corticosteroids, dermatological preparations <0.1%    
Desoximetasone D07 Corticosteroids, dermatological preparations <0.1%    
Dexamethasone H02 Corticosteroids for systemic use <0.1%    
Dexamethasone and antiinfectives S01 Ophthalmologicals <0.1%    
Dexamfetamine N06 Psychoanaleptics 0.1%    
Dexlansoprazole A02 Drugs for acid related disorders <0.1%    
Diazepam N05 Psycholeptics <0.1%    
Diazoxide C02 Antihypertensives <0.1%  
Diclofenac M01 Antiinflammatory and antirheumatic products 0.1%    
Diclofenac, combinations M01 Antiinflammatory and antirheumatic products 0.2%    
Dicycloverine A03 Drugs for functional gastrointestinal disorders <0.1%    
Dienogest G03 Sex hormones and modulators of the genital system <0.1%    
Diflucortolone D07 Corticosteroids, dermatological preparations <0.1%    
Digoxin C01 Cardiac therapy <0.1%    
Dihydroergotamine N02 Analgesics <0.1%    
Diltiazem C08 Calcium channel blockers 0.7%    
Dimethyl fumarate N07 Other nervous system drugs 0.5%  
Dimethyl sulfoxide G04 Urologicals <0.1%    
Diphenhydramine R06 Antihistamines for systemic use <0.1%    
Diphenoxylate A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%  
Dipyridamole B01 Antithrombotic agents <0.1%  
Disopyramide C01 Cardiac therapy <0.1%  
Domperidone A03 Drugs for functional gastrointestinal disorders <0.1%    
Donepezil N06 Psychoanaleptics 0.4%    
Dornase alfa (desoxyribonuclease) R05 Cough and cold preparations <0.1%  
Dorzolamide S01 Ophthalmologicals <0.1%    
Doxazosin C02 Antihypertensives <0.1%    
Doxepin N06 Psychoanaleptics <0.1%    
Doxycycline J01 Antibacterials for systemic use <0.1%    
Doxylamine, combinations R06 Antihistamines for systemic use 0.1%    
Dronedarone C01 Cardiac therapy <0.1%    
Drospirenone and estrogen G03 Sex hormones and modulators of the genital system <0.1%  
Duloxetine N06 Psychoanaleptics 1.5%  
Dutasteride G04 Urologicals 0.2%  
Eculizumab L04 Immunosuppressants 0.3%  
Eletriptan A03 Drugs for functional gastrointestinal disorders <0.1%  
Eltrombopag B02 Antihemorrhagics <0.1%  
Enalapril C09 Agents acting on the renin-angiotensin system 0.2%    
Enalapril and diuretics C09 Agents acting on the renin-angiotensin system <0.1%    
Enoxaparin B01 Antithrombotic agents 0.2%    
Entacapone N04 Anti-Parkinson drugs <0.1%    
Entecavir J05 Antivirals for systemic use <0.1%    
Epinephrine C01 Cardiac therapy 0.2%  
Eplerenone C03 Diuretics <0.1%    
Epoprostenol B01 Antithrombotic agents <0.1%  
Eprosartan C09 Agents acting on the renin-angiotensin system <0.1%    
Eprosartan and diuretics C09 Agents acting on the renin-angiotensin system <0.1%    
Ergoloid mesylates C04 Peripheral vasodilators <0.1%    
Ergotamine, combinations excluding psycholeptics N02 Analgesics <0.1%    
Ertapenem J01 Antibacterials for systemic use <0.1%  
Erythromycin J01 Antibacterials for systemic use <0.1%  
Erythromycin, combinations D10 Anti-acne preparations <0.1%  
Escitalopram N06 Psychoanaleptics 0.4%  
Eslicarbazepine N03 Antiepileptics <0.1%  
Esomeprazole A02 Drugs for acid related disorders 0.2%    
Estradiol G03 Sex hormones and modulators of the genital system 0.3%    
Estrone G03 Sex hormones and modulators of the genital system <0.1%    
Etacrynic acid C03 Diuretics <0.1%    
Etanercept L04 Immunosuppressants 2.2%  
Ethosuximide N03 Antiepileptics <0.1%    
Etidronic acid M05 Drugs for treatment of bone diseases <0.1%    
Etidronic acid and calcium, sequential M05 Drugs for treatment of bone diseases <0.1%    
Etodolac M01 Antiinflammatory and antirheumatic products <0.1%  
Etynodiol and estrogen G03 Sex hormones and modulators of the genital system <0.1%  
Ezetimibe C10 Lipid modifying agents 0.3%    
Famciclovir J05 Antivirals for systemic use <0.1%    
Famotidine A02 Drugs for acid related disorders <0.1%    
Febuxostat M04 Antigout preparations <0.1%  
Felodipine C08 Calcium channel blockers 0.2%    
Fenofibrate C10 Lipid modifying agents 0.2%    
Fenoterol and ipratropium bromide R03 Drugs for obstructive airway diseases <0.1%  
Fentanyl N01 Anesthetics 0.4%  
Fesoterodine G04 Urologicals <0.1%    
Fidaxomicin A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%    
Filgrastim L03 Immunostimulants 0.7%    
Finasteride G04 Urologicals 0.1%  
Fingolimod L04 Immunosuppressants 0.3%
Flecainide C01 Cardiac therapy <0.1%    
Fluconazole J02 Antimycotics for systemic use <0.1%    
Fludrocortisone H02 Corticosteroids for systemic use <0.1%    
Flumetasone and antibiotics D07 Corticosteroids, dermatological preparations <0.1%    
Flumetasone and antiinfectives S02 Otologicals <0.1%    
Flunarizine N07 Other nervous system drugs <0.1%    
Flunisolide R01 Nasal preparations <0.1%    
Fluocinolone acetonide D07 Corticosteroids, dermatological preparations <0.1%    
Fluocinonide D07 Corticosteroids, dermatological preparations <0.1%    
Fluorometholone S01 Ophthalmologicals <0.1%    
Fluoxetine N06 Psychoanaleptics 0.3%    
Flupentixol N05 Psycholeptics <0.1%    
Fluphenazine N05 Psycholeptics <0.1%    
Flurazepam N05 Psycholeptics <0.1%    
Flurbiprofen M01 Antiinflammatory and antirheumatic products <0.1%    
Fluticasone R03 Drugs for obstructive airway diseases 0.9%    
Fluticasone furoate R03 Drugs for obstructive airway diseases <0.1%    
Fluvastatin C10 Lipid modifying agents <0.1%    
Fluvoxamine N06 Psychoanaleptics <0.1%    
Follitropin alfa G03 Sex hormones and modulators of the genital system <0.1%    
Follitropin beta G03 Sex hormones and modulators of the genital system <0.1%    
Fondaparinux B01 Antithrombotic agents <0.1%    
Formoterol R03 Drugs for obstructive airway diseases <0.1%    
Formoterol and budesonide R03 Drugs for obstructive airway diseases 1.1%    
Formoterol and mometasone R03 Drugs for obstructive airway diseases 0.1%    
Fosfomycin J01 Antibacterials for systemic use <0.1%    
Fosinopril C09 Agents acting on the renin-angiotensin system <0.1%  
Framycetin D09 Medicated dressings <0.1%  
Furosemide C03 Diuretics 0.2%    
Fusidic acid D06 Antibiotics and chemotherapeutics for dermatological use 0.1%    
Gabapentin N03 Antiepileptics 0.7%    
Galantamine N06 Psychoanaleptics 0.1%    
Ganciclovir J05 Antivirals for systemic use <0.1%    
Ganirelix acetate H01 Pituitary and hypothalamic hormones and analogues <0.1%    
Gatifloxacin J01 Antibacterials for systemic use <0.1%    
Gemfibrozil C10 Lipid modifying agents <0.1%    
Gentamicin J01 Antibacterials for systemic use <0.1%    
Glatiramer acetate L03 Immunostimulants 0.5%
Glibenclamide A10 Drugs used in diabetes <0.1%    
Gliclazide A10 Drugs used in diabetes 0.3%    
Glimepiride A10 Drugs used in diabetes <0.1%    
Glucagon H04 Pancreatic hormones <0.1%  
Glyceryl trinitrate C01 Cardiac therapy 0.2%    
Glycopyrronium A03 Drugs for functional gastrointestinal disorders <0.1%    
Glycopyrronium bromide R03 Drugs for obstructive airway diseases <0.1%    
Golimumab L04 Immunosuppressants 0.5%  
Gonadorelin acetate H01 Pituitary and hypothalamic hormones and analogues <0.1%    
Gonadotrophine chorionique G03 Sex hormones and modulators of the genital system <0.1%
Goserelin L02 Endocrine therapy 0.3%    
Granisetron A04 Antiemetics and antinauseants <0.1%  
Griseofulvin D01 Antifungals for dermatological use <0.1%  
Guanfacine HCl C02 Antihypertensives <0.1%    
Haloperidol N05 Psycholeptics <0.1%    
Heparin B01 Antithrombotic agents <0.1%    
Hexachlorophene D08 Antiseptics and disinfectants <0.1%  
Homatropine S01 Ophthalmologicals <0.1%    
Hydralazine C02 Antihypertensives <0.1%    
Hydrochlorothiazide C03 Diuretics <0.1%    
Hydrochlorothiazide and potassium-sparing agents C03 Diuretics <0.1%    
Hydrocodone R05 Cough and cold preparations <0.1%    
Hydrocortisone A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents 0.2%    
Hydrocortisone and antibiotics D07 Corticosteroids, dermatological preparations <0.1%    
Hydrocortisone and antiinfectives S01 Ophthalmologicals <0.1%    
Hydrocortisone, combinations C05 Vasoprotectives <0.1%    
Hydromorphone N02 Analgesics 1.2%    
Hydroxychloroquine P01 Antiprotozoals 0.1%    
Hydroxyquinoline derivatives P01 Antiprotozoals <0.1%    
Hydroxyzine N05 Psycholeptics <0.1%    
Ibuprofen M01 Antiinflammatory and antirheumatic products <0.1%    
Imidazoles/triazoles in combination with corticosteroids D01 Antifungals for dermatological use <0.1%  
Imipenem and enzyme inhibitor J01 Antibacterials for systemic use <0.1%    
Imipramine N06 Psychoanaleptics <0.1%    
Imiquimod D06 Antibiotics and chemotherapeutics for dermatological use <0.1%    
Indacaterol R03 Drugs for obstructive airway diseases <0.1%    
Indacaterol and glycopyrronium bromide R03 Drugs for obstructive airway diseases <0.1%    
Indapamide C03 Diuretics <0.1%  
Indometacin M01 Antiinflammatory and antirheumatic products <0.1%  
Infliximab L04 Immunosuppressants 5.1%
Insulin (human) A10 Drugs used in diabetes 0.7%
Insulin (pork) A10 Drugs used in diabetes <0.1%    
Insulin aspart A10 Drugs used in diabetes 0.7%    
Insulin detemir A10 Drugs used in diabetes 0.5%    
Insulin glargine A10 Drugs used in diabetes 1.8%    
Insulin glulisine A10 Drugs used in diabetes <0.1%    
Insulin lispro A10 Drugs used in diabetes 0.6%    
Interferon alfa-2b L03 Immunostimulants <0.1%    
Interferon beta-1a L03 Immunostimulants 0.6%
Interferon beta-1b L03 Immunostimulants 0.1%
Ipratropium bromide R01 Nasal preparations 0.2%    
Irbesartan C09 Agents acting on the renin-angiotensin system 0.2%    
Irbesartan and diuretics C09 Agents acting on the renin-angiotensin system <0.1%    
Isosorbide dinitrate C01 Cardiac therapy <0.1%    
Isosorbide mononitrate C01 Cardiac therapy <0.1%    
Isotretinoin D10 Anti-acne preparations <0.1%    
Itraconazole J02 Antimycotics for systemic use <0.1%    
Ivacaftor R07 Other respiratory system products 0.2%  
Ketoconazole D01 Antifungals for dermatological use <0.1%    
Ketoprofen M01 Antiinflammatory and antirheumatic products <0.1%    
Ketorolac M01 Antiinflammatory and antirheumatic products <0.1%    
Ketotifen R06 Antihistamines for systemic use <0.1%    
Labetalol C07 Beta blocking agents <0.1%    
Lacosamide N03 Antiepileptics 0.1%    
Lactic acid producing organisms A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%    
Lamivudine J05 Antivirals for systemic use <0.1%    
Lamotrigine N03 Antiepileptics 0.2%    
Lanreotide H01 Pituitary and hypothalamic hormones and analogues <0.1%
Lansoprazole A02 Drugs for acid related disorders 0.4%  
Lansoprazole, amoxicillin and clarithromycin A02 Drugs for acid related disorders <0.1%    
Lanthanum carbonate V03 All other therapeutic products <0.1%    
Latanoprost S01 Ophthalmologicals 0.1%    
Leflunomide L04 Immunosuppressants 0.1%    
Leuprorelin L02 Endocrine therapy 0.5%  
Levetiracetam N03 Antiepileptics 0.2%    
Levobunolol S01 Ophthalmologicals <0.1%    
Levocarnitine A16 Other alimentary tract and metabolism products <0.1%  
Levodopa and decarboxylase inhibitor N04 Anti-Parkinson drugs 0.4%  
Levodopa, decarboxylase inhibitor, and COMT inhibitor N04 Anti-Parkinson drugs <0.1%  
Levofloxacin J01 Antibacterials for systemic use <0.1%    
Levomepromazine N05 Psycholeptics <0.1%    
Levonorgestrel and estrogen G03 Sex hormones and modulators of the genital system 0.2%    
Levothyroxine sodium H03 Thyroid therapy 0.4%    
Lidocaine D04 Antipruritics, incl. Antihistamines, anesthetics, etc. <0.1%    
Linagliptin A10 Drugs used in diabetes 0.4%    
Lincomycin J01 Antibacterials for systemic use <0.1%    
Linezolid J01 Antibacterials for systemic use <0.1%  
Liothyronine sodium H03 Thyroid therapy <0.1%    
Liraglutide A10 Drugs used in diabetes <0.1%    
Lisdexamfetamine N06 Psychoanaleptics 0.2%    
Lisinopril C09 Agents acting on the renin-angiotensin system <0.1%    
Lisinopril and diuretics C09 Agents acting on the renin-angiotensin system <0.1%    
Lithium N05 Psycholeptics <0.1%    
Lodoxamide S01 Ophthalmologicals <0.1%  
Loperamide A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%    
Lorazepam N05 Psycholeptics 0.1%    
Losartan C09 Agents acting on the renin-angiotensin system 0.1%    
Losartan and diuretics C09 Agents acting on the renin-angiotensin system <0.1%    
Lovastatin C10 Lipid modifying agents <0.1%    
Loxapine N05 Psycholeptics <0.1%    
Lurasidone N05 Psycholeptics <0.1%    
Macitentan C02 Antihypertensives <0.1%
Mebendazole P02 Anthelmintics <0.1%    
Medroxyprogesterone G03 Sex hormones and modulators of the genital system <0.1%    
Mefenamic acid M01 Antiinflammatory and antirheumatic products <0.1%    
Mefloquine HCl P01 Antiprotozoals <0.1%    
Megestrol L02 Endocrine therapy <0.1%    
Meloxicam M01 Antiinflammatory and antirheumatic products <0.1%    
Memantine N06 Psychoanaleptics <0.1%    
Meropenem J01 Antibacterials for systemic use <0.1%    
Mesalazine A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents 0.6%    
Mesuximide N03 Antiepileptics <0.1%  
Metformin A10 Drugs used in diabetes 0.5%  
Metformin and linagliptin A10 Drugs used in diabetes <0.1%    
Metformin and rosiglitazone A10 Drugs used in diabetes <0.1%    
Metformin and saxagliptin A10 Drugs used in diabetes <0.1%    
Metformin and sitagliptin A10 Drugs used in diabetes 1.0%  
Methadone N07 Other nervous system drugs 0.3%    
Methazolamide S01 Ophthalmologicals <0.1%    
Methenamine J01 Antibacterials for systemic use <0.1%  
Methocarbamol, combinations excluding psycholeptics M03 Muscle relaxants <0.1%    
Methoxalen, topical D05 Antipsoriatics <0.1%    
Methyldopa (racemic) C02 Antihypertensives <0.1%    
Methylphenidate N06 Psychoanaleptics 0.5%    
Methylprednisolone D10 Anti-acne preparations <0.1%    
Methylprednisolone, combinations H02 Corticosteroids for systemic use <0.1%  
Metoclopramide A03 Drugs for functional gastrointestinal disorders <0.1%  
Metolazone C03 Diuretics <0.1%  
Metoprolol C07 Beta blocking agents 0.3%    
Metronidazole D06 Antibiotics and chemotherapeutics for dermatological use <0.1%    
Mexiletine C01 Cardiac therapy <0.1%    
Miconazole D01 Antifungals for dermatological use <0.1%    
Midazolam N05 Psycholeptics <0.1%    
Midodrine C01 Cardiac therapy <0.1%    
Milrinone lactate C01 Cardiac therapy <0.1%    
Minocycline J01 Antibacterials for systemic use <0.1%    
Minoxidil C02 Antihypertensives <0.1%  
Mirtazapine N06 Psychoanaleptics 0.1%    
Misoprostol A02 Drugs for acid related disorders <0.1%    
Moclobemide N06 Psychoanaleptics <0.1%    
Modafinil N06 Psychoanaleptics <0.1%    
Mometasone D07 Corticosteroids, dermatological preparations 0.2%    
Montelukast R03 Drugs for obstructive airway diseases <0.1%    
Morphine N02 Analgesics 0.4%    
Moxifloxacin J01 Antibacterials for systemic use 0.1%    
Multienzymes (lipase, protease etc.) A09 Digestives, incl. Enzymes 0.2%  
Mycophenolic acid L04 Immunosuppressants 0.3%    
Nabilone A04 Antiemetics and antinauseants 0.2%    
Nabumetone M01 Antiinflammatory and antirheumatic products <0.1%    
Nadolol C07 Beta blocking agents <0.1%    
Nadroparin B01 Antithrombotic agents <0.1%    
Nafarelin H01 Pituitary and hypothalamic hormones and analogues <0.1%    
Naltrexone N07 Other nervous system drugs <0.1%    
Naproxen M01 Antiinflammatory and antirheumatic products 0.2%    
Naratriptan N02 Analgesics <0.1%    
Natalizumab L04 Immunosuppressants 0.1%  
Nateglinide A10 Drugs used in diabetes <0.1%  
Nedocromil R03 Drugs for obstructive airway diseases <0.1%    
Neomycin D06 Antibiotics and chemotherapeutics for dermatological use <0.1%    
Neostigmine N07 Other nervous system drugs <0.1%    
Nepafenac S01 Ophthalmologicals <0.1%    
Nicotinic acid C04 Peripheral vasodilators <0.1%    
Nifedipine C08 Calcium channel blockers 0.9%  
Nimodipine C08 Calcium channel blockers <0.1%  
Nitrazepam N05 Psycholeptics <0.1%    
Nitrofurantoin J01 Antibacterials for systemic use 0.1%    
Nizatidine A02 Drugs for acid related disorders <0.1%    
Norelgestromin and estrogen G03 Sex hormones and modulators of the genital system <0.1%  
Norethisterone G03 Sex hormones and modulators of the genital system <0.1%    
Norethisterone and estrogen G03 Sex hormones and modulators of the genital system <0.1%    
Norfloxacin J01 Antibacterials for systemic use <0.1%    
Norgestimate and estrogen G03 Sex hormones and modulators of the genital system 0.2%    
Nortriptyline N06 Psychoanaleptics 0.1%    
Nystatin A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%    
Nystatin, combinations G01 Gynecological antiinfectives and antiseptics <0.1%  
Ocriplasmin S01 Ophthalmologicals <0.1%  
Octreotide H01 Pituitary and hypothalamic hormones and analogues 0.5%    
Ofloxacin S01 Ophthalmologicals <0.1%    
Olanzapine N05 Psycholeptics 0.5%    
Olmesartan medoxomil C09 Agents acting on the renin-angiotensin system 0.3%    
Olmesartan medoxomil and diuretics C09 Agents acting on the renin-angiotensin system 0.2%    
Olopatadine S01 Ophthalmologicals <0.1%  
Olsalazine A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%    
Omalizumab R03 Drugs for obstructive airway diseases 0.2%  
Omeprazole A02 Drugs for acid related disorders 0.5%    
Ondansetron A04 Antiemetics and antinauseants 0.2%    
Opium N02 Analgesics <0.1%    
Opium derivatives and expectorants R05 Cough and cold preparations <0.1%  
Oral rehydration salt formulations A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%    
Orciprenaline R03 Drugs for obstructive airway diseases <0.1%    
Orlistat A08 Antiobesity preparations, excl. Diet products <0.1%    
Orphenadrine (citrate) M03 Muscle relaxants <0.1%    
Other aminoglycosides J01 Antibacterials for systemic use <0.1%    
Other antiemetics A04 Antiemetics and antinauseants <0.1%    
Oxazepam N05 Psycholeptics <0.1%    
Oxcarbazepine N03 Antiepileptics <0.1%    
Oxybutynin G04 Urologicals <0.1%    
Oxycodone N02 Analgesics 0.5%    
Oxycodone, combinations N02 Analgesics <0.1%    
Paliperidone N05 Psycholeptics 0.9%  
Pamidronic acid M05 Drugs for treatment of bone diseases <0.1%    
Pantoprazole A02 Drugs for acid related disorders 1.9%    
Papaverine A03 Drugs for functional gastrointestinal disorders <0.1%    
Paraldehyde N05 Psycholeptics <0.1%    
Paromomycin A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%  
Paroxetine N06 Psychoanaleptics 0.3%  
Pegfilgrastim L03 Immunostimulants <0.1%  
Peginterferon alfa-2a L03 Immunostimulants <0.1%    
Peginterferon alfa-2a, combinations L03 Immunostimulants <0.1%    
Peginterferon alfa-2b, combinations L03 Immunostimulants <0.1%    
Penicillamine M01 Antiinflammatory and antirheumatic products <0.1%    
Pentamidine isethionate P01 Antiprotozoals <0.1%    
Pentazocine N02 Analgesics <0.1%    
Pentostan polysulfate sodium C05 Vasoprotectives <0.1%  
Pentoxifylline C04 Peripheral vasodilators <0.1%  
Perampanel N03 Antiepileptics <0.1%  
Periciazine N05 Psycholeptics <0.1%    
Perindopril C09 Agents acting on the renin-angiotensin system 1.5%    
Perindopril and diuretics C09 Agents acting on the renin-angiotensin system 0.5%  
Perphenazine N05 Psycholeptics <0.1%    
Pethidine N02 Analgesics <0.1%    
Phenelzine N06 Psychoanaleptics <0.1%  
Phenobarbital N03 Antiepileptics <0.1%    
Phenoxymethylpenicillin J01 Antibacterials for systemic use <0.1%    
Phenylephrine S01 Ophthalmologicals <0.1%    
Phenytoin N03 Antiepileptics <0.1%    
Phosphodiesterase inhibitors C01 Cardiac therapy <0.1%    
Phytomenadione B02 Antihemorrhagics <0.1%    
Pilocarpine N07 Other nervous system drugs <0.1%    
Pimecrolimus D11 Other dermatological preparations <0.1%  
Pimozide N05 Psycholeptics <0.1%  
Pinaverium A03 Drugs for functional gastrointestinal disorders <0.1%  
Pindolol C07 Beta blocking agents <0.1%  
Pindolol and other diuretics C07 Beta blocking agents <0.1%  
Pioglitazone A10 Drugs used in diabetes <0.1%    
Piperacillin and enzyme inhibitor J01 Antibacterials for systemic use <0.1%    
Pipotiazine N05 Psycholeptics <0.1%  
Piroxicam M01 Antiinflammatory and antirheumatic products <0.1%    
Pizotifen N02 Analgesics <0.1%    
Plastic IUD with progestogens G02 Other gynecologicals 0.2%    
Plerixafor L03 Immunostimulants <0.1%  
Podophyllotoxin D06 Antibiotics and chemotherapeutics for dermatological use <0.1%    
Polystyrene sulphonate V03 All other therapeutic products <0.1%  
Posaconazole J02 Antimycotics for systemic use <0.1%
Pramipexole N04 Anti-Parkinson drugs <0.1%  
Prasugrel B01 Antithrombotic agents <0.1%  
Pravastatin C10 Lipid modifying agents 0.2%  
Praziquantel P02 Anthelmintics <0.1%  
Prazosin C02 Antihypertensives <0.1%    
Prednisolone H02 Corticosteroids for systemic use 0.1%    
Prednisolone and antiinfectives S01 Ophthalmologicals <0.1%    
Prednisone H02 Corticosteroids for systemic use <0.1%    
Pregabalin N03 Antiepileptics 0.3%    
Primaquine P01 Antiprotozoals <0.1%  
Primidone N03 Antiepileptics <0.1%  
Probenecid M04 Antigout preparations <0.1%  
Prochlorperazine N05 Psycholeptics <0.1%    
Procyclidine N04 Anti-Parkinson drugs <0.1%    
Profenamine N04 Anti-Parkinson drugs <0.1%  
Progesterone G03 Sex hormones and modulators of the genital system <0.1%    
Promethazine R06 Antihistamines for systemic use <0.1%    
Propafenone C01 Cardiac therapy <0.1%    
Propranolol C07 Beta blocking agents <0.1%    
Propylthiouracil H03 Thyroid therapy <0.1%    
Protease inhibitors J05 Antivirals for systemic use <0.1%
Proxymetacaine S01 Ophthalmologicals <0.1%    
Pyridostigmine N07 Other nervous system drugs <0.1%    
Quetiapine N05 Psycholeptics 0.7%    
Quinagolide G02 Other gynecologicals <0.1%  
Quinapril C09 Agents acting on the renin-angiotensin system 0.1%  
Quinapril and diuretics C09 Agents acting on the renin-angiotensin system <0.1%    
Quinidine C01 Cardiac therapy <0.1%    
Quinine P01 Antiprotozoals <0.1%    
Rabeprazole A02 Drugs for acid related disorders 0.5%    
Raloxifene G03 Sex hormones and modulators of the genital system <0.1%    
Ramipril C09 Agents acting on the renin-angiotensin system 0.7%    
Ramipril and diuretics C09 Agents acting on the renin-angiotensin system <0.1%    
Ranitidine A02 Drugs for acid related disorders 0.3%    
Rasagiline N04 Anti-Parkinson drugs <0.1%  
Repaglinide A10 Drugs used in diabetes <0.1%  
Ribavirin J05 Antivirals for systemic use <0.1%  
Rifaximin A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%    
Riluzole N07 Other nervous system drugs <0.1%  
Riociguat C02 Antihypertensives <0.1%
Risedronic acid M05 Drugs for treatment of bone diseases 0.7%    
Risperidone N05 Psycholeptics 0.7%    
Rivaroxaban B01 Antithrombotic agents 1.0%  
Rivastigmine N06 Psychoanaleptics <0.1%    
Rizatriptan N02 Analgesics <0.1%    
Romiplostim B02 Antihemorrhagics <0.1%
Ropinirole N04 Anti-Parkinson drugs <0.1%
Rosiglitazone A10 Drugs used in diabetes <0.1%  
Rosuvastatin C10 Lipid modifying agents 1.3%  
Rufinamide N03 Antiepileptics <0.1%  
Salbutamol R03 Drugs for obstructive airway diseases 0.4%    
Salbutamol and ipratropium bromide R03 Drugs for obstructive airway diseases <0.1%    
Salmeterol R03 Drugs for obstructive airway diseases <0.1%    
Salmeterol and fluticasone R03 Drugs for obstructive airway diseases 2.4%    
Sapropterin A16 Other alimentary tract and metabolism products <0.1%  
Saxagliptin A10 Drugs used in diabetes 0.3%    
Scopolamine A04 Antiemetics and antinauseants <0.1%    
Secukinumab L04 Immunosuppressants <0.1%    
Selegiline N04 Anti-Parkinson drugs <0.1%    
Sertraline N06 Psychoanaleptics 0.3%    
Sevelamer V03 All other therapeutic products <0.1%  
Sildenafil G04 Urologicals <0.1%  
Silodosin G04 Urologicals 0.2%  
Silver sulfadiazine D06 Antibiotics and chemotherapeutics for dermatological use <0.1%    
Simvastatin C10 Lipid modifying agents 0.4%    
Sirolimus L04 Immunosuppressants <0.1%    
Sitagliptin A10 Drugs used in diabetes 1.3%    
Sodium aurothiomalate M01 Antiinflammatory and antirheumatic products <0.1%    
Sodium tetradecyl sulphate C05 Vasoprotectives <0.1%    
Sofosbuvir J05 Antivirals for systemic use 1.3%  
Sofosbuvir and ledipasvir J05 Antivirals for systemic use 5.2%  
Solifenacin G04 Urologicals 0.2%
Somatropin H01 Pituitary and hypothalamic hormones and analogues 0.2%
Sotalol C07 Beta blocking agents <0.1%    
Spiramycin J01 Antibacterials for systemic use <0.1%    
Spironolactone C03 Diuretics <0.1%    
Stiripentol N03 Antiepileptics <0.1%  
Sucralfate A02 Drugs for acid related disorders <0.1%    
Sufentanil N01 Anesthetics <0.1%    
Sulfamethoxazole J01 Antibacterials for systemic use <0.1%    
Sulfamethoxazole and trimethoprim J01 Antibacterials for systemic use <0.1%    
Sulfasalazine A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%    
Sulfinpyrazone M04 Antigout preparations <0.1%    
Sulindac M01 Antiinflammatory and antirheumatic products <0.1%    
Sulphur, combinations D10 Anti-acne preparations <0.1%  
Sumatriptan N02 Analgesics 0.1%    
Tacrolimus D11 Other dermatological preparations 0.4%    
Tamsulosin G04 Urologicals 0.2%    
Tazarotene D05 Antipsoriatics <0.1%  
Telmisartan C09 Agents acting on the renin-angiotensin system 0.2%  
Telmisartan and amlodipine C09 Agents acting on the renin-angiotensin system <0.1%  
Telmisartan and diuretics C09 Agents acting on the renin-angiotensin system <0.1%    
Temazepam N05 Psycholeptics <0.1%    
Tenofovir disoproxil J05 Antivirals for systemic use 0.5%  
Tenoxicam M01 Antiinflammatory and antirheumatic products <0.1%    
Terazosin G04 Urologicals <0.1%    
Terbinafine D01 Antifungals for dermatological use <0.1%    
Terbutaline R03 Drugs for obstructive airway diseases <0.1%  
Terconazole G01 Gynecological antiinfectives and antiseptics <0.1%  
Teriflunomide L04 Immunosuppressants 0.1%  
Teriparatide H05 Calcium homeostasis <0.1%    
Testosterone G03 Sex hormones and modulators of the genital system 0.1%    
Tetrabenazine N07 Other nervous system drugs <0.1%    
Tetracosactide H01 Pituitary and hypothalamic hormones and analogues <0.1%
Tetracycline J01 Antibacterials for systemic use <0.1%    
Theophylline R03 Drugs for obstructive airway diseases <0.1%    
Theophylline, combinations excluding psycholeptics R03 Drugs for obstructive airway diseases <0.1%  
Thiamazole H03 Thyroid therapy <0.1%      
Thioridazine N05 Psycholeptics <0.1%  
Thyroid gland preparations H03 Thyroid therapy <0.1%    
Thyrotrophin V04 Diagnostic agents <0.1%    
Tiaprofenic acid M01 Antiinflammatory and antirheumatic products <0.1%  
Ticagrelor B01 Antithrombotic agents 0.1%  
Ticlopidine B01 Antithrombotic agents <0.1%    
Tigecycline J01 Antibacterials for systemic use <0.1%  
Timolol S01 Ophthalmologicals <0.1%    
Timolol, combinations S01 Ophthalmologicals 0.5%    
Tinzaparin B01 Antithrombotic agents 0.2%    
Tiotixene N05 Psycholeptics <0.1%    
Tiotropium bromide R03 Drugs for obstructive airway diseases 1.5%    
Tizanidine M03 Muscle relaxants <0.1%    
Tobramycin J01 Antibacterials for systemic use 0.1%    
Tocilizumab L04 Immunosuppressants 0.2%
Tofacitinib L04 Immunosuppressants <0.1%  
Tolbutamide A10 Drugs used in diabetes <0.1%    
Tolterodine G04 Urologicals 0.3%    
Topiramate N03 Antiepileptics 0.2%    
Trandolapril C09 Agents acting on the renin-angiotensin system 0.3%  
Trandolapril and verapamil HCl C09 Agents acting on the renin-angiotensin system <0.1%    
Tranexamic acid B02 Antihemorrhagics <0.1%  
Tranylcypromine N06 Psychoanaleptics <0.1%  
Travoprost S01 Ophthalmologicals <0.1%    
Trazodone N06 Psychoanaleptics <0.1%    
Treprostinil B01 Antithrombotic agents <0.1%
Tretinoin D10 Anti-acne preparations <0.1%    
Triamcinolone A01 Stomatological preparations <0.1%    
Triamcinolone and antibiotics D07 Corticosteroids, dermatological preparations <0.1%    
Triazolam N05 Psycholeptics <0.1%    
Trifluoperazine N05 Psycholeptics <0.1%    
Trifluridine S01 Ophthalmologicals <0.1%    
Trihexyphenidyl N04 Anti-Parkinson drugs <0.1%    
Trimebutine A03 Drugs for functional gastrointestinal disorders <0.1%    
Trimethoprim J01 Antibacterials for systemic use <0.1%    
Trimipramine N06 Psychoanaleptics <0.1%    
Triptorelin L02 Endocrine therapy <0.1%  
Tropicamide S01 Ophthalmologicals <0.1%  
Trospium G04 Urologicals <0.1%  
Tryptophan N06 Psychoanaleptics <0.1%  
Ulipristal G03 Sex hormones and modulators of the genital system <0.1%    
Ulobetasol D07 Corticosteroids, dermatological preparations <0.1%    
Urinary antispasmodics G04 Urologicals <0.1%    
Urinary concrement solvents G04 Urologicals <0.1%    
Urofollitropin G03 Sex hormones and modulators of the genital system <0.1%    
Ursodeoxycholic acid A05 Bile and liver therapy 0.1%    
Ustekinumab L04 Immunosuppressants 0.5%
Vaginal ring with progestogen and estrogen G02 Other gynecologicals <0.1%    
Valaciclovir J05 Antivirals for systemic use 0.5%    
Valganciclovir J05 Antivirals for systemic use <0.1%    
Valproic acid N03 Antiepileptics 0.2%    
Valsartan C09 Agents acting on the renin-angiotensin system 0.2%    
Valsartan and diuretics C09 Agents acting on the renin-angiotensin system 0.1%    
Vancomycin A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents <0.1%    
Varenicline N07 Other nervous system drugs 0.2%  
Venlafaxine N06 Psychoanaleptics 0.5%    
Verapamil C08 Calcium channel blockers <0.1%    
Vigabatrin N03 Antiepileptics <0.1%    
Vilanterol and fluticasone furoate R03 Drugs for obstructive airway diseases <0.1%    
Vilanterol and umeclidinium bromide R03 Drugs for obstructive airway diseases <0.1%    
Voriconazole J02 Antimycotics for systemic use <0.1%  
Warfarin B01 Antithrombotic agents 0.2%  
Wart and anti-corn preparations D11 Other dermatological preparations <0.1%  
Yohimbin G04 Urologicals <0.1%  
Zafirlukast R03 Drugs for obstructive airway diseases <0.1%    
Ziprasidone N05 Psycholeptics <0.1%    
Zoledronic acid M05 Drugs for treatment of bone diseases <0.1%  
Zolmitriptan N02 Analgesics <0.1%    
Zopiclone N05 Psycholeptics 0.2%    
Zuclopenthixol N05 Psycholeptics <0.1%    

* Based on the Anatomical Therapeutic Chemical (ATC) level 5 as reported by the Canadian Institute for Health Information.

ATC level 2 as reported by the Canadian Institute for Health Information.

Date modified: